Proteasome inhibition causes nigral degeneration with inclusion bodies in rats

NeuroReport

Volumn 13, Issue 11, 2002, Pages 1437-1441

  McNaught, Kevin St P ^a   Björklund, Lars M ^a   Belizaire, Roger ^a   Isacson, Ole ^a   Jenner, Peter ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Lactacystin; Lewy body inclusion; Parkin; Parkinson's disease; Substantia nigra pars compacta; Ubiquitin proteasome system; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; APOMORPHINE; LACTACYSTIN; PROTEASOME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRADYKINESIA; CELL INCLUSION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ENZYME INHIBITION; HEAD TILTING; LEWY BODY; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENICITY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0037036904     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200208070-00018     Document Type: Article

References (23)

1. Forno LS. J Neuropathol Exp Neurol 55, 259-272 (1996).
2. McNaught KS, Olanow CW, Halliwell B et al. Nature Rev Neurosci 2, 589-594 (2001).
3. Shimura H, Schlossmacher MG, Hattori N et al. Science 293, 263-269 (2001).
4. Leroy E, Boyer R, Auburger G et al. Nature 395, 451-452 (1998).
5. McNaught KSP, Mytilineou C, JnoBaptiste R et al. J Neurochem 81, 301-306 (2002).
6. Polymeropoulos MH, Lavedan C, Leroy E et al. Science 276, 2045-2047 (1997).
7. Kruger R, Kuhn W, Muller T et al. Nature Genet 18, 106-108 (1998).
8. Spira PJ, Sharpe DM, Halliday G et al. Ann Neurol 49, 313-319 (2001).
9. Tofaris GK, Layfield R and Spillantini MG. FEBS Lett 509, 22-26 (2001).
10. Bennett MC, Bishop JF, Leng Y et al. J Biol Chem 274, 33855-33858 (1999).
11. Tanaka Y, Engelender S, Igarashi S et al. Hum Mol Genet 10, 919-926 (2001).
12. Spillantini MG, Crowther PA, Jakes R et al. Proc Natl Acad Sci USA 95, 6469-6473 (1998).
13. Good PF, Hsu A, Werner P et al. J Neuropathol Exp Neurol 57, 338-342 (1998).
14. Alam ZI, Daniel SE, Lees AJ et al. J Neurochem 69, 1326-1329 (1997).
15. McNaught KS, Belezaire R, Jenner P et al. Neurosci Lett 326, 155-158 (2002).
16. McNaught KS and Jenner P. Neurosci Lett 297, 191-194 (2001).
17. Rideout HJ, Larsen KE, Sulzer D et al. J Neurochem 78, 899-908 (2001).
18. McNaught KS, Thull U, Carrupt PA et al. Neurodegeneration 5, 265-274 (1996).
19. Moore AE, Cicchetti F, Hennen J et al. Exp Neurol 172, 363-376 (2001).
20. Craiu A, Gaczynska M, Akopian T et al. J Biol Chem 272, 13437-13445 (1997).
21. Hirsch EC, Faucheux B, Damier P et al. J Neural Transm Suppl 50, 79-88 (1997).
22. Lee HJ, Shin SY, Choi C et al. J Biol Chem 27, 27 (2001).
23. Johnston JA, Ward CL and Kopito RR. J Cell Biol 143, 1883-1898 (1998).